pizza on glp 1 GLP-1 is changing how America eats Some of the biggest names
Description
Only 40% of 2023 initiators remained on therapy after a year compared to 34% of 2022 initiators and 33% of 2021 initiators
Youve likely heard about glucagon-like peptide-1 agonists commonly referred to as GLP-1 medications, and more widely recognized through pharmaceutical brand names like Ozempic and Mounjaro.
Because the cost of care rises as patient comorbidities increase, the value of treatment also increases
Genetic predispositions in GLP-1 receptor pathways and individual biomarkers may help inform personalized selection conversations with providers
Individual results vary
The company has a big opportunity to serve needle-phobic patients.
